SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-18-042557
Filing Date
2018-02-13
Accepted
2018-02-13 16:17:20
Documents
1
Group Members
KEVIN P. STARRMARK LEVINROBERT I. TEPPERTHIRD ROCK VENTURES GP, L.P.TRV GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d518508dsc13ga.htm SC 13G/A 126342
  Complete submission text file 0001193125-18-042557.txt   127988
Mailing Address 29 NEWBURY STREET SUITE 401 BOSTON MA 02116
Business Address 29 NEWBURY STREET SUITE 401 BOSTON MA 02116 617-859-3099
THIRD ROCK VENTURES LP (Filed by) CIK: 0001408591 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Subject) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89140 | Film No.: 18603575
SIC: 2834 Pharmaceutical Preparations